Free Trial
NASDAQ:NRBO

NeuroBo Pharmaceuticals (NRBO) Stock Price, News & Analysis

NeuroBo Pharmaceuticals logo
$0.71 -0.01 (-1.13%)
As of 07/14/2025

About NeuroBo Pharmaceuticals Stock (NASDAQ:NRBO)

Key Stats

Today's Range
$0.69
$0.72
50-Day Range
$0.62
$0.81
52-Week Range
$2.08
$5.16
Volume
82,490 shs
Average Volume
39,095 shs
Market Capitalization
$6.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NRBO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

NRBO Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
NeuroBo Pharmaceuticals Rebrands Amidst Strategic Changes
NeuroBo Pharmaceuticals announces relignment, change name
See More Headlines

NRBO Stock Analysis - Frequently Asked Questions

NeuroBo Pharmaceuticals' stock was trading at $2.03 at the beginning of 2025. Since then, NRBO stock has decreased by 65.0% and is now trading at $0.7099.

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) issued its quarterly earnings results on Thursday, November, 7th. The company reported ($0.55) earnings per share for the quarter, beating the consensus estimate of ($0.82) by $0.27.

Shares of NeuroBo Pharmaceuticals reverse split on Thursday, December 21st 2023.The 1-8 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Shares of NRBO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeuroBo Pharmaceuticals investors own include Meta Platforms (META), NVIDIA (NVDA), Broadcom (AVGO), CymaBay Therapeutics (CBAY), CrowdStrike (CRWD), GE Aerospace (GE) and Adobe (ADBE).

Company Calendar

Last Earnings
11/07/2024
Today
7/15/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Banking
Current Symbol
NASDAQ:NRBO
CIK
1638287
Employees
10
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.47 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-189.12%
Return on Assets
-122.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.41
Quick Ratio
2.41

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.50 per share
Price / Book
0.47

Miscellaneous

Outstanding Shares
8,616,000
Free Float
8,526,000
Market Cap
$6.12 million
Optionable
Not Optionable
Beta
-0.26
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:NRBO) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners